Suren G. Dutia
Director · CITIUS ONCOLOGY, INC.
Individual
- 2024
- Dec 22, 2025
- 5
Other insiders active in the same sector
No other insider has filed at Suren G. Dutia's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- WARBURG PINCUS CO. - $1.12B in SHC purchases and sales in the last 12 months
- CP Circle ML Holdco GP, LLC - $1.07B in MDLN purchases and sales in the last 12 months
- TC Group Cayman Investment Holdings, L.P. - $1.07B in MDLN purchases and sales in the last 12 months
- Martine A. Rothblatt - $798.23M in UTHR purchases and sales in the last 12 months
- TPG GP A, LLC - $742.97M in LFST purchases and sales in the last 12 months
- GTCR INVESTMENT XI LLC - $639.50M in SHC purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Suren G. Dutia?
Suren G. Dutia is a corporate insider, tracked as Director of CITIUS ONCOLOGY, INC. (CTOR). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Suren G. Dutia last file a Form 4?
The most recent primary Form 4 on record is dated 22 December 2025, one of 5 filings going back to 2024.
